Basso M - Search Results

1

A reversible coma after oxaliplatin administration suggests a pathogenetic role of electrolyte imbalance.

Basso M, Cassano A, Modoni A, Spada D, Trigila N, Quirino M, Schinzari G, Barone C. Basso M, et al. Eur J Clin Pharmacol. 2008 Jul;64(7):739-41. doi: 10.1007/s00228-008-0474-x. Epub 2008 Mar 19. Eur J Clin Pharmacol. 2008. PMID: 18350285 No abstract available.

2

Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity.

Basso M, Modoni A, Spada D, Cassano A, Schinzari G, Lo Monaco M, Quaranta D, Tonali PA, Barone C. Basso M, et al. Cancer Chemother Pharmacol. 2011 May;67(5):1179-87. doi: 10.1007/s00280-010-1466-y. Epub 2010 Sep 25. Cancer Chemother Pharmacol. 2011. PMID: 20872144

3

Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer.

Barone C, Basso M, Schinzari G, Pozzo C, Trigila N, D'Argento E, Quirino M, Astone A, Cassano A. Barone C, et al. Among authors: basso m. Gastric Cancer. 2007;10(2):104-11. doi: 10.1007/s10120-007-0415-x. Epub 2007 Jun 25. Gastric Cancer. 2007. PMID: 17577620 Clinical Trial.

4

Oxaliplatin, neurotoxicity, and the search for the lost channel.

Modoni A, Basso M. Modoni A, et al. Among authors: basso m. J Peripher Nerv Syst. 2019 Dec;24(4):359. doi: 10.1111/jns.12355. Epub 2019 Nov 6. J Peripher Nerv Syst. 2019. PMID: 31696577 No abstract available.

5

Unexpected side effect in mCRC: A care-compliant case report of regorafenib-induced hyperammonemic encephalopathy.

Quirino M, Rossi S, Schinzari G, Basso M, Strippoli A, Cassano A, Barone C. Quirino M, et al. Among authors: basso m. Medicine (Baltimore). 2017 Apr;96(16):e6522. doi: 10.1097/MD.0000000000006522. Medicine (Baltimore). 2017. PMID: 28422839 Free PMC article.

6

First-line Treatment of Advanced Biliary Ducts Carcinoma: A Randomized Phase II Study Evaluating 5-FU/LV Plus Oxaliplatin (Folfox 4) Versus 5-FU/LV (de Gramont Regimen).

Schinzari G, Rossi E, Mambella G, Strippoli A, Cangiano R, Mutignani M, Basso M, Cassano A, Barone C. Schinzari G, et al. Among authors: basso m. Anticancer Res. 2017 Sep;37(9):5193-5197. doi: 10.21873/anticanres.11942. Anticancer Res. 2017. PMID: 28870954 Clinical Trial.

7

ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis.

Strippoli A, Rossi S, Martini M, Basso M, D'Argento E, Schinzari G, Barile R, Cassano A, Barone C. Strippoli A, et al. Among authors: basso m. Oncotarget. 2016 Jun 7;7(23):35159-68. doi: 10.18632/oncotarget.9063. Oncotarget. 2016. PMID: 27147577 Free PMC article.

8

A survey of therapy for advanced renal cell carcinoma.

Basso M, Cassano A, Barone C. Basso M, et al. Urol Oncol. 2010 Mar-Apr;28(2):121-33. doi: 10.1016/j.urolonc.2009.04.015. Epub 2009 Jul 3. Urol Oncol. 2010. PMID: 19576800 Review.

9

Temsirolimus: is improved survival the correct expression of drug activity?

Basso M, Cassano A, Schinzari G, Barone C. Basso M, et al. Oncologist. 2010;15(7):790-1; author reply 792. doi: 10.1634/theoncologist.2010-0099. Oncologist. 2010. PMID: 20667970 Free PMC article.

10

Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review.

Rossi S, Schinzari G, Basso M, Strippoli A, Dadduzio V, D'Argento E, Cassano A, Barone C. Rossi S, et al. Among authors: basso m. Future Oncol. 2016 May;12(10):1299-307. doi: 10.2217/fon-2015-0065. Epub 2016 Mar 21. Future Oncol. 2016. PMID: 26996100 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

857 results

Search Page

Filters